View Our Blog Articles

By Vinay Saranga September 5, 2025
Spravato is an FDA-approved nasal spray that works differently than traditional antidepressants. While most medications target serotonin or norepinephrine, Spravato boosts glutamate, which helps the brain form new connections. In simple terms, it helps “rewire” parts of the brain affected by depression.
By Vinay Saranga August 27, 2025
ADHD is one of the most common childhood mental health conditions, and while it comes with challenges, it is also highly treatable. At the North Carolina Institute of Advanced NeuroHealth, we want parents to know they don’t have to figure this out alone.
By Vinay Saranga August 7, 2025
At the North Carolina Institute of Advanced NeuroHealth, we want you to know that if your family is struggling with back-to-school anxiety or stress, you are far from alone.
By Vinay Saranga June 27, 2025
The truth is, depression can be complicated, and medication doesn’t always fix everything on its own. Lots of people don’t get the results they hope for just by taking antidepressants.
By Vinay Saranga May 28, 2025
In Fuquay-Varina and the surrounding areas, The North Carolina Institute of Advanced NeuroHealth offers care that’s rooted in compassion and respect.
By Vinay Saranga April 24, 2025
Traditional antidepressants are often the first option people try, but for some, they simply don’t do enough to bring real change. It can be discouraging when medications that worked for others don’t seem to help you, and it might make you feel like you’re running out of options.
By Vinay Saranga March 14, 2025
We’re excited to announce the expansion of our services with a brand-new office in Fuquay-Varina, NC! This new location allows us to bring expert medication management and innovative treatments like Spravato to even more people in our community. If you’ve been looking for compassionate, high-quality mental health care, we’re here for you.
By Vinay Saranga February 18, 2025
Innovative treatments like Spravato (esketamine) and ketamine therapy are changing the way we treat depression and anxiety—giving hope to those who need it most.
By Vinay Saranga January 28, 2025
For people in Apex, NC, and beyond who have struggled with depression that seems unyielding, there’s exciting news: the FDA has approved Spravato (esketamine) as the first-ever stand-alone therapy for treatment-resistant depression. This groundbreaking treatment offers new hope to those who haven’t found relief through traditional medications.
More Posts